STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
Article excerpt
Highlighted: the sentence this signal was extracted from
• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries • This strategic manufacturing investment is the largest in STERIS's history in a single site • New 600,000 square foot campus will create 335 jobs in North Carolina DUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub to produce high-performance infection prevention and contamination control chemistries used across the Healthcare and Pharmaceutical industries. The construction of these facilities will include several phases, and the new site is expected to become operational in 2-3 years, starting with distribution. Upon completion, STERIS expects to transition its existing manufacturing and distribution of chemistries from St. Louis, Missouri and Plymouth, Minnesota to this new Center of Excellence. "After extensive analysis of our existing facilities and Customer demand, we have decided to make a significant investment in the United States to support our long-term global growth," said Dan Carestio, President and CEO of STERIS...
Keep reading with a free account
The rest of this article, and every signal for Steris, is in your free account.